With accessible courses, inspiring lecturers, and friends you make for life, release your potential in this incredible city and start a career you'll feel proud of.

Cell and gene therapies (CGTs ... suggests a lack of knowledge or understanding of the potential benefits. Access Is Limited in CGT Deserts Another key barrier is geography.

The Allen Brain Cell Atlas (ABC Atlas) aims to empower researchers worldwide to explore and analyze multiple whole-brain datasets simultaneously. As the Allen Institute and its collaborators continue ...

Medical Science and Technology Innovation Center, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan 250117, China Center for Biomechanics and Bioengineering, Beijing Key ...

That’s why most students will enjoy an innovative approach to learning using block teaching, where you will study one module at a time ... discusses the benefits of undertaking the Practice Nursing ...

That’s why most of our postgraduate taught students will enjoy an innovative approach to learning using block teaching, where you will study one module at a time ... Our block-taught courses are ...

"With this analysis confirming our initial theory, we can now take steps toward solving the challenge of transplant access." Allogenic hematopoietic stem cell transplant is an important therapy ...

One barrier is access to AP courses, especially for underserved students. Only a few states have provided universal access to AP courses as well as a test fee waiver. One of those states is Arkansas.

A major issue with gene and cell therapies is the upfront cost. While these treatments can be life changing, they are expensive and costs can be as high as $4.25 million for treating one patient. So ...

For millions of people living in remote areas, reliable internet access has been a luxury. But with Starlink's direct-to-cell technology ... known as the "Of Course I Still Love You" droneship.

The agency granted approval to durvalumab for the treatment of a subset of patients with limited-stage small cell lung cancer. The FDA granted approval to durvalumab (Imfinzi) to treat patients with ...